Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
DAR Darling Ingredients
- 36.780
- -1.780-4.62%
Close Feb 26 16:00 ET
- 37.430
- +0.650+1.77%
Post 19:06 ET
5.84BMarket Cap21.26P/E (TTM)
38.680High36.640Low2.32MVolume38.680Open38.560Pre Close85.80MTurnover1.48%Turnover Ratio21.26P/E (Static)158.87MShares48.39052wk High1.33P/B5.78BFloat Cap32.55052wk Low--Dividend TTM157.08MShs Float87.590Historical High--Div YieldTTM5.29%Amplitude0.250Historical Low37.006Avg Price1Lot Size
Darling Ingredients Key Stats
Quarterly+Annual
YOY
| (FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.81%5.72B | -12.17%1.42B | -12.51%1.42B | -17.20%1.46B | -20.71%1.42B | 3.92%6.79B | -8.71%1.61B | -7.00%1.63B | 6.51%1.76B | 1.79B |
| Operating revenue | -15.81%5.72B | -12.17%1.42B | -12.51%1.42B | -17.20%1.46B | -20.71%1.42B | 3.92%6.79B | -8.71%1.61B | -7.00%1.63B | 6.51%1.76B | --1.79B |
| Cost of revenue | -13.72%4.44B | -7.96%1.08B | -10.53%1.11B | -17.01%1.13B | -18.31%1.12B | 2.81%5.14B | -14.62%1.18B | -9.66%1.24B | 10.41%1.36B | 1.37B |
| Gross profit | -22.32%1.28B | -23.52%333.76M | -18.86%313.57M | -17.85%326.87M | -28.42%303.63M | 7.55%1.65B | 12.25%436.43M | 2.69%386.47M | -4.96%397.92M | 424.2M |
| Operating expense | -4.65%995.93M | -12.89%235.67M | -9.26%239.27M | -1.74%254.34M | 6.04%266.65M | 25.65%1.04B | 13.15%270.55M | 25.53%263.69M | 28.85%258.84M | 251.47M |
| Selling and administrative expenses | -9.30%492.11M | -18.93%107.51M | -15.96%115.72M | -5.13%129.73M | 2.71%139.14M | 24.26%542.53M | 8.95%132.62M | 31.04%137.7M | 26.88%136.75M | --135.47M |
| Depreciation amortization depletion | 0.36%503.83M | -7.08%128.16M | -1.94%123.55M | 2.06%124.61M | 9.92%127.51M | 27.18%502.02M | 17.50%137.93M | 20.02%125.99M | 31.12%122.09M | --116.01M |
| -Depreciation and amortization | 0.36%503.83M | -7.08%128.16M | -1.94%123.55M | 2.06%124.61M | 9.92%127.51M | 27.18%502.02M | 17.50%137.93M | 20.02%125.99M | 31.12%122.09M | --116.01M |
| Operating profit | -53.05%281.91M | -40.87%98.09M | -39.48%74.3M | -47.85%72.54M | -78.59%36.98M | -14.01%600.47M | 10.82%165.88M | -26.17%122.78M | -36.14%139.08M | 172.73M |
| Net non-operating interest income expense | 2.07%-253.86M | 19.78%-54.91M | 4.88%-66.85M | 1.38%-69.23M | -25.00%-62.88M | -106.44%-259.22M | -48.36%-68.45M | -76.51%-70.28M | -192.37%-70.19M | -50.3M |
| Non-operating interest expense | -2.07%253.86M | -19.78%54.91M | -4.88%66.85M | -1.38%69.23M | 25.00%62.88M | 106.44%259.22M | 48.36%68.45M | 76.51%70.28M | 192.37%70.19M | --50.3M |
| Other net income (expense) | -42.05%219.46M | 1,297.51%35.05M | -109.65%-5.81M | -65.28%78.83M | 18.00%111.39M | 17.97%378.71M | -103.12%-2.93M | -40.40%60.22M | 288.88%227.02M | 94.4M |
| Gain on sale of security | -114.19%-1.15M | -710.19%-1.67M | -115.86%-134K | -83.41%413K | -95.28%236K | 172.12%8.13M | 96.09%-206K | 271.40%845K | 156.44%2.49M | --5M |
| Earnings from equity interest | -56.63%161.08M | 334.35%26.92M | -88.89%6.21M | -78.02%47.21M | -14.53%80.73M | -1.60%371.39M | -94.95%6.2M | -47.10%55.92M | 182.83%214.81M | --94.46M |
| Special income (charges) | 317.38%37.23M | 102.67%313K | -1,485.42%-16.63M | 584.99%31.77M | 294.04%21.77M | 58.78%-17.13M | 50.89%-11.74M | 186.52%1.2M | 136.07%4.64M | ---11.22M |
| -Less：Restructuring and merger&acquisition | -234.73%-33.07M | -81.31%3.74M | 869.09%16.37M | -553.30%-31.99M | -283.57%-21.2M | -46.68%24.55M | -16.02%20.03M | -147.28%-2.13M | -135.19%-4.9M | --11.55M |
| -Gain on sale of property,plant,equipment | -43.98%4.16M | -51.03%4.06M | 72.98%-251K | 14.29%-222K | 75.54%574K | 65.13%7.42M | 12,648.48%8.28M | -129.81%-929K | -124.55%-259K | --327K |
| Other non- operating income (expenses) | 36.78%22.31M | 235.79%9.49M | 110.73%4.74M | -111.18%-568K | 40.54%8.66M | 551.93%16.31M | 1,067.36%2.83M | 180.05%2.25M | 1,781.79%5.08M | --6.16M |
| Income before tax | -65.62%247.51M | -17.22%78.23M | -98.54%1.64M | -72.24%82.14M | -60.57%85.5M | -19.44%719.96M | -52.08%94.5M | -50.46%112.72M | 17.35%295.91M | 216.83M |
| Income tax | -164.36%-38.34M | -452.57%-25.55M | -13.71%-17.47M | -98.10%774K | -85.52%3.91M | -59.37%59.57M | -80.93%7.25M | -143.63%-15.36M | -13.99%40.71M | 26.97M |
| Net income | -56.72%285.85M | 18.93%103.78M | -85.08%19.12M | -68.12%81.37M | -57.03%81.59M | -11.61%660.39M | -45.20%87.26M | -33.40%128.08M | 24.59%255.2M | 189.86M |
| Net income continuous Operations | -56.72%285.85M | 18.93%103.78M | -85.08%19.12M | -68.12%81.37M | -57.03%81.59M | -11.61%660.39M | -45.20%87.26M | -33.40%128.08M | 24.59%255.2M | --189.86M |
| Minority interest income | -45.00%6.97M | -31.79%1.87M | -29.10%2.17M | -11.19%2.5M | -89.37%431K | 34.68%12.66M | 2.58%2.74M | 150.41%3.06M | -0.67%2.81M | 4.05M |
| Net income attributable to the parent company | -56.94%278.88M | 20.58%101.91M | -86.44%16.95M | -68.75%78.87M | -56.32%81.16M | -12.20%647.73M | -46.02%84.52M | -34.57%125.03M | 24.94%252.38M | 185.8M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -56.94%278.88M | 20.58%101.91M | -86.44%16.95M | -68.75%78.87M | -56.32%81.16M | -12.20%647.73M | -46.02%84.52M | -34.57%125.03M | 24.94%252.38M | 185.8M |
| Basic earnings per share | -56.79%1.75 | 20.75%0.64 | -85.90%0.11 | -68.99%0.49 | -56.03%0.51 | -11.57%4.05 | -45.92%0.53 | -34.45%0.78 | 26.40%1.58 | 1.16 |
| Diluted earnings per share | -56.64%1.73 | 21.15%0.63 | -85.71%0.11 | -68.39%0.49 | -56.14%0.5 | -11.14%3.99 | -45.83%0.52 | -34.19%0.77 | 26.02%1.55 | 1.14 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |